Fundraising Fox
/Companies
Sign in

Glen Clova Scientific

4 known investors

Find your way into Glen Clova Scientific

Sign up to see every warm intro you have to Glen Clova Scientific

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Glen Clova Scientific team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Glenclova Scientific develops a virus-like particle (VLP) platform that displays therapeutic proteins and peptides to enhance the efficacy and reduce the dosage requirements of biologic drugs. The platform targets chronic disease treatments, particularly for inflammatory, respiratory, dermatological, and oncological indications, with a focus on improved accessibility and affordability for resource-limited healthcare settings.

AI & Machine LearningBiotechDeep TechHealthtech

Founders & leadership

DJ
Dr John FoersterScientific Founder
JHJamie Hodgson
Jamie HodgsonChief Executive OfficerJamie Hodgson held leadership positions at Insignia Technologies Ltd and Antibody Analytics before becoming Chief Executive Officer of Glen Clova Scientific, which develops a virus-like particle platform for delivering therapeutic proteins and peptides in biologic drugs.

Investors · 4

Scottish EnterprisereportedGlasgow

How we know: funding news · tech.eu · Not right? Tell us

Also in the syndicate · 2

Norcliffe CapitalleadTRICAPITAL Angels

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Glen Clova Scientific do?
Glenclova Scientific develops a virus-like particle (VLP) platform that displays therapeutic proteins and peptides to enhance the efficacy and reduce the dosage requirements of biologic drugs. The platform targets chronic disease treatments, particularly for inflammatory, respiratory, dermatological, and oncological indications, with a focus on improved accessibility and affordability for resource-limited healthcare settings.
Who founded Glen Clova Scientific?
Glen Clova Scientific was founded by Dr John Foerster.
Who are Glen Clova Scientific's investors?
Glen Clova Scientific's investors include DSW Ventures, Scottish Enterprise.